BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home » Authors » Tamra Sami

Articles by Tamra Sami

Australia's Bionomics revives BNC-210 in PTSD following analysis of phase II failure

Feb. 20, 2019
By Tamra Sami
PERTH, Australia – Adelaide-based Bionomics Inc. is reviving lead compound BNC-210 after a deeper analysis of phase II data showed a positive effect in post-traumatic stress disorder (PTSD).
Read More

Stakeholders oppose New Zealand's transparent approach in drug reclassification model

Feb. 20, 2019
By Tamra Sami
PERTH, Australia – Although industry stakeholders were generally supportive of New Zealand's Medicines and Medical Devices Safety Authority (Medsafe) proposed changes to the reclassification system for drugs in New Zealand, most vehemently opposed the idea of posting completed applications on the Medsafe website, citing competitive intellectual property concerns.
Read More

Stakeholders oppose New Zealand's transparent approach in drug reclassification model

Feb. 19, 2019
By Tamra Sami
PERTH, Australia – Although industry stakeholders were generally supportive of New Zealand's Medicines and Medical Devices Safety Authority (Medsafe) proposed changes to the reclassification system for drugs in New Zealand, most vehemently opposed the idea of posting completed applications on the Medsafe website, citing competitive intellectual property concerns.
Read More

Minomic spins out immuno-oncology company Glytherix

Feb. 15, 2019
By Tamra Sami

In drug pricing battle, Australia opts for pricing certainty over access to new therapies

Feb. 13, 2019
By Tamra Sami
PERTH, Australia – As pharma companies face global pricing pressures, value-based pricing mechanisms and health technology assessments more often than not determine which drugs get reimbursed and, ultimately, make it to the patient.
Read More

In drug pricing battle, Australia opts for pricing certainty over access to new therapies

Feb. 8, 2019
By Tamra Sami
PERTH, Australia – As pharma companies face global pricing pressures, value-based pricing mechanisms and health technology assessments more often than not determine which drugs get reimbursed and, ultimately, make it to the patient.
Read More

Global Kinetics' PKG yields real-world data to change management of PD patients

Feb. 7, 2019
By Tamra Sami

Australia's medical research institutes delivering on the promise of innovation

Feb. 6, 2019
By Tamra Sami

Australia's medical research institutes delivering on the promise of innovation

Feb. 6, 2019
By Tamra Sami
PERTH, Australia – Australia's medical research institutes generated more than 18,000 research contracts and collaborations in 2016, which resulted in more than AU$1.9 billion (US$1.37 billion) in income, according to a new survey conducted by Australia's Department of Industry, Innovation and Science.
Read More

Australia's medical research institutes delivering on the promise of innovation

Feb. 5, 2019
By Tamra Sami
PERTH, Australia – Australia's medical research institutes generated more than 18,000 research contracts and collaborations in 2016, which resulted in more than AU$1.9 billion (US$1.37 billion) in income, according to a new survey conducted by Australia's Department of Industry, Innovation and Science.
Read More
Previous 1 2 … 196 197 198 199 200 201 202 203 204 … 233 234 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 10, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • 3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

    Skape Bio unlocks GPCR targets with de novo-designed miniproteins

    BioWorld
    Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
  • Wuxi Apptec signage

    Wuxi Apptec insists it’s ‘not a Chinese military company’

    BioWorld
    Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
  • Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors

    BioWorld Science
    Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing